Qube Research & Technologies Ltd
Position in RIGL — Rigel Pharmaceuticals Inc
CIK 1729829
LONDON, X0
Position in RIGL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$9,298,974
-$3,047,587 QoQ
Shares Held
343,897
+19.3% QoQ
Ownership
1.84%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in RIGL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Qube Research & Technologies Ltd holds $2,443,068,185 across 169 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
798,715 | $240,437,176 | |
| 2 | INSM |
INSMED Inc
|
1,682,334 | $179,370,451 | |
| 3 | REGN |
Regeneron Pharmaceuticals, Inc.
|
221,607 | $138,180,828 | |
| 4 | ROIV |
Roivant Sciences Ltd.
|
3,454,496 | $122,254,613 | |
| 5 | AXSM |
Axsome Therapeutics, Inc.
|
426,336 | $104,354,262 | |
| 6 | APGE |
Apogee Therapeutics, Inc.
|
659,678 | $87,559,060 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
1,443,230 | $81,989,896 | |
| 8 | RPRX |
Royalty Pharma plc
|
1,412,112 | $79,177,119 |
All Filings in RIGL
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $9,298,974 | 343,897 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $12,346,561 | 288,269 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $10,226,166 | 360,966 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $3,210,771 | 171,424 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $2,781,559 | 154,617 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,984,036 | 117,957 | Shares | Sole | 2025-02-14 | |
| 2024-06-30 | $145,222 | 17,667 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $134,247 | 90,708 | Shares | Sole | 2024-05-14 | |
| 2023-09-30 | $134,277 | 124,331 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $194,547 | 150,812 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $624,843 | 473,366 | Shares | Sole | 2023-05-15 | |
| 2022-09-30 | $680,395 | 576,606 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $334,894 | 112,005 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $272,462 | 102,816 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $404,559 | 111,449 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $84,078 | 19,373 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $311,852 | 91,185 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $145,033 | 41,438 | Shares | Sole | 2021-02-16 | |
| No filing history on record for this holder in this stock. | ||||||